Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.
We examined the incidence, risk factors and associated mortality of acute renal failure requiring dialysis (Renal Bearman Grade [BG] 3) in a 3-year cohort of 97 consecutive allogeneic blood and marrow transplantation (alloBMT) patients. In all, 20 (21%) developed Renal BG3 (all died by day +132) and 77 (79%) developed renal insufficiency (Renal BG1-2). Renal BG3 was a contributing or primary cause of death in 18 (90%) patients who continued to require dialysis at time of death. The two Renal BG3 patients whose deaths were not related to renal failure died on day +103 of hemorrhage and day +132 of underlying disease. By univariate analysis, age, unrelated donor, veno-occlusive disease (VOD) and grade III-IV acute graft-versus-host disease with hepatic involvement were significantly associated with Renal BG3. The multivariate model of time to Renal BG3 determined only a prior diagnosis of severe acute GVHD (RR=4.1, 95% CI 1.6-10.3, P=0.003) and VOD (RR=9.1, 95% CI 3.5-23.7, P<0.001) as significant independent predictors. Renal BG3 is generally considered a conditioning regimen-related toxicity. This study demonstrates that Renal BG3 is most commonly a complication of hepatic co-morbidities after allogeneic blood and marrow transplantation and identifies patients with a very poor prognosis.
Hahn
T
T
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Rondeau
C
C
Shaukat
A
A
Jupudy
V
V
Miller
A
A
Alam
A R
AR
Baer
M R
MR
Bambach
B
B
Bernstein
Z
Z
Chanan-Khan
A A
AA
Czuczman
M S
MS
Slack
J
J
Wetzler
M
M
Mookerjee
B K
BK
Silva
J
J
McCarthy
P L
PL
D058186:Acute Kidney Injury / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion / Q000379:methods*; D016026:Bone Marrow Transplantation; D002648:Child; D015331:Cohort Studies; D006086:Graft vs Host Disease / Q000517:prevention & control / Q000628:therapy; D006504:Hepatic Veno-Occlusive Disease / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous